S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NASDAQ:NKNantkwest News Headlines

$11.07
-0.97 (-8.06 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.87
Now: $11.07
$11.99
50-Day Range
$8.05
MA: $12.08
$15.36
52-Week Range
$1.04
Now: $11.07
$15.70
Volume1.60 million shs
Average Volume2.06 million shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.03

Headlines

Nantkwest (NASDAQ NK) News Headlines

Source:
DateHeadline
Zacks Investment Research Downgrades Nantkwest (NASDAQ:NK) to SellZacks Investment Research Downgrades Nantkwest (NASDAQ:NK) to Sell
marketbeat.com - July 9 at 5:53 AM
Short Interest in Nantkwest Inc (NASDAQ:NK) Declines By 9.8%Short Interest in Nantkwest Inc (NASDAQ:NK) Declines By 9.8%
americanbankingnews.com - August 3 at 5:54 PM
Nantkwest (NASDAQ:NK) Shares Gap Down to $11.18Nantkwest (NASDAQ:NK) Shares Gap Down to $11.18
americanbankingnews.com - August 3 at 4:28 PM
ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins - Yahoo FinanceImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins - Yahoo Finance
finance.yahoo.com - August 3 at 9:24 AM
NantKwest (NK) Announces ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins - StreetInsider.comNantKwest (NK) Announces ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins - StreetInsider.com
www.streetinsider.com - August 3 at 9:24 AM
NantKwest Inc.NantKwest Inc.
www.marketwatch.com - August 2 at 12:34 AM
Nantkwest (NASDAQ:NK)  Shares Down 16.8% Nantkwest (NASDAQ:NK) Shares Down 16.8%
www.americanbankingnews.com - July 31 at 8:51 PM
Analysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceAnalysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
finance.yahoo.com - July 28 at 5:31 PM
Analysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - July 28 at 5:31 PM
Nantkwest (NASDAQ:NK) Trading Down 8.8% on Insider SellingNantkwest (NASDAQ:NK) Trading Down 8.8% on Insider Selling
www.americanbankingnews.com - July 23 at 6:40 PM
5 Stock Gainers for Monday: Daqo New Energy, BioXcel, Livongo - TheStreet5 Stock Gainers for Monday: Daqo New Energy, BioXcel, Livongo - TheStreet
www.thestreet.com - July 20 at 6:27 PM
Nantkwest (NASDAQ:NK) Sets New 52-Week High at $15.35Nantkwest (NASDAQ:NK) Sets New 52-Week High at $15.35
www.americanbankingnews.com - July 20 at 1:32 PM
Jeopardy host Alex Trebek opens up in new book - Los Angeles Times'Jeopardy' host Alex Trebek opens up in new book - Los Angeles Times
www.latimes.com - July 20 at 1:26 PM
Relative Strength Alert: Will the Nantkwest Inc (NSQ:NK) share price keep rising? - Yahoo Finance UKRelative Strength Alert: Will the Nantkwest Inc (NSQ:NK) share price keep rising? - Yahoo Finance UK
uk.finance.yahoo.com - July 15 at 1:16 PM
Head-To-Head Contrast: AVITA MED LTD/S (NASDAQ:RCEL) & Nantkwest (NASDAQ:NK)Head-To-Head Contrast: AVITA MED LTD/S (NASDAQ:RCEL) & Nantkwest (NASDAQ:NK)
www.americanbankingnews.com - July 13 at 3:56 PM
Brokers Issue Forecasts for Nantkwest Incs Q2 2020 Earnings (NASDAQ:NK)Brokers Issue Forecasts for Nantkwest Inc's Q2 2020 Earnings (NASDAQ:NK)
www.americanbankingnews.com - July 13 at 1:18 AM
Piper Sandler Starts NantKwest (NK) at Overweight - StreetInsider.comPiper Sandler Starts NantKwest (NK) at Overweight - StreetInsider.com
www.streetinsider.com - July 8 at 11:07 PM
The Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More Shares - Yahoo FinanceThe Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More Shares - Yahoo Finance
finance.yahoo.com - July 2 at 3:36 PM
The Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More SharesThe Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More Shares
finance.yahoo.com - July 2 at 10:36 AM
NantKwest Announces Closing of $90.7 Million Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares - Business WireNantKwest Announces Closing of $90.7 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire
www.businesswire.com - June 29 at 11:30 PM
NantKwest Announces Closing of $90.7 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo FinanceNantKwest Announces Closing of $90.7 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance
finance.yahoo.com - June 29 at 6:27 PM
NantKwest Announces Pricing of Public Offering of Common Stock - Yahoo FinanceNantKwest Announces Pricing of Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - June 26 at 9:19 AM
Form 8-K NantKwest, Inc. For: Jun 24 - StreetInsider.comForm 8-K NantKwest, Inc. For: Jun 24 - StreetInsider.com
www.streetinsider.com - June 25 at 11:53 PM
NantKwest Announces Pricing of Public Offering of Common Stock - Business WireNantKwest Announces Pricing of Public Offering of Common Stock - Business Wire
www.businesswire.com - June 25 at 8:52 AM
NantKwest (NK) Plans Public Offering of Common Stock - StreetInsider.comNantKwest (NK) Plans Public Offering of Common Stock - StreetInsider.com
www.streetinsider.com - June 25 at 12:28 AM
NantKwest readies equity raise - Seeking AlphaNantKwest readies equity raise - Seeking Alpha
seekingalpha.com - June 24 at 7:27 PM
NantKwest Announces Proposed Public Offering of Common Stock - Business WireNantKwest Announces Proposed Public Offering of Common Stock - Business Wire
www.businesswire.com - June 24 at 7:27 PM
NantKwest Announces Proposed Public Offering of Common StockNantKwest Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 24 at 7:27 PM
Why Tortoise Acquisition Stock Just Popped Another 25% Today - NasdaqWhy Tortoise Acquisition Stock Just Popped Another 25% Today - Nasdaq
www.nasdaq.com - June 22 at 11:03 PM
Heres Why NantKwest Rocketed Higher TodayHere's Why NantKwest Rocketed Higher Today
www.fool.com - June 22 at 6:03 PM
Stock Alert: NantKwest Up 17%Stock Alert: NantKwest Up 17%
www.nasdaq.com - June 22 at 1:02 PM
Thinking about buying stock in Virgin Galactic, Miragen Therapeutics, Nantkwest Inc, Agenus Inc, or Norwegian Cruise Line?Thinking about buying stock in Virgin Galactic, Miragen Therapeutics, Nantkwest Inc, Agenus Inc, or Norwegian Cruise Line?
www.prnewswire.com - June 22 at 9:44 AM
NantKwest Announces Studies in Collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line Tested - Yahoo FinanceNantKwest Announces Studies in Collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line Tested - Yahoo Finance
finance.yahoo.com - June 11 at 2:53 PM
NantKwest Announces Studies in Collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line TestedNantKwest Announces Studies in Collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line Tested
finance.yahoo.com - June 10 at 12:22 PM
Hedge Funds Cashing Out Of Nantkwest Inc (NK) - Yahoo FinanceHedge Funds Cashing Out Of Nantkwest Inc (NK) - Yahoo Finance
finance.yahoo.com - June 1 at 12:22 AM
Hedge Funds Cashing Out Of Nantkwest Inc (NK)Hedge Funds Cashing Out Of Nantkwest Inc (NK)
finance.yahoo.com - June 1 at 12:22 AM
NantKwest Vaccine Now Part Of Operation Warp Speed, Lays Out Plan For COVID-19 Candidates - Yahoo FinanceNantKwest Vaccine Now Part Of 'Operation Warp Speed,' Lays Out Plan For COVID-19 Candidates - Yahoo Finance
finance.yahoo.com - May 28 at 2:59 PM
NantKwest (NK) option implied volatility is at 210 as shares rally 44% - StreetInsider.comNantKwest (NK) option implied volatility is at 210 as shares rally 44% - StreetInsider.com
www.streetinsider.com - May 27 at 6:08 PM
NantKwest Vaccine Now Part Of Operation Warp Speed, Lays Out Plan For COVID-19 CandidatesNantKwest Vaccine Now Part Of 'Operation Warp Speed,' Lays Out Plan For COVID-19 Candidates
finance.yahoo.com - May 27 at 6:08 PM
BRIEF-ImmunityBio, NantKwest Sign COVID-19 Joint Development, Manufacturing, Marketing Agreement - ReutersBRIEF-ImmunityBio, NantKwest Sign COVID-19 Joint Development, Manufacturing, Marketing Agreement - Reuters
www.reuters.com - May 27 at 1:08 PM
ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for Operation Warp Speed to Develop Novel Adenovirus COVID-19 Vaccine - Business WireImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for 'Operation Warp Speed' to Develop Novel Adenovirus COVID-19 Vaccine - Business Wire
www.businesswire.com - May 27 at 1:08 PM
ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 VaccineImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine
finance.yahoo.com - May 27 at 1:08 PM
Global Apheresis Equipment Market to surpass US$ 6081.8 Mn globally by end of 2027 – Coherent Market Insights - GlobeNewswireGlobal Apheresis Equipment Market to surpass US$ 6081.8 Mn globally by end of 2027 – Coherent Market Insights - GlobeNewswire
www.globenewswire.com - May 26 at 2:32 PM
NantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare ConferenceNantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 26 at 2:32 PM
NantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference - Business WireNantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference - Business Wire
www.businesswire.com - May 26 at 9:31 AM
Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths - Business WireBe The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths - Business Wire
www.businesswire.com - May 21 at 2:39 PM
Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 DeathsBe The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths
finance.yahoo.com - May 19 at 10:07 AM
NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients - Business WireNantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients - Business Wire
www.businesswire.com - May 18 at 6:56 PM
NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 PatientsNantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients
finance.yahoo.com - May 18 at 8:55 AM
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPOThe Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
finance.yahoo.com - May 15 at 12:31 PM
NantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer - Business WireNantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer - Business Wire
www.businesswire.com - May 14 at 8:46 PM
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.